Therefore, based on these results we hypothesize that the p53 pathway and its ability to induce a G1 cell-cycle arrest in tumor cells (Figure 5A) may play a role in the differential response of lung cancers to one or two fractions of RT. The gene discussed is TP53; the disease is neoplasm.